130 related articles for article (PubMed ID: 13129566)
21. Nanoprodrug of retinoic acid-modified paclitaxel.
Zhou Z; Yan J; Sun T; Wang X; Xie Z
Org Biomol Chem; 2017 Nov; 15(45):9611-9615. PubMed ID: 29106434
[TBL] [Abstract][Full Text] [Related]
22. N6-cyclopropyl-PMEDAP: a novel derivative of 9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine (PMEDAP) with distinct metabolic, antiproliferative, and differentiation-inducing properties.
Hatse S; Naesens L; De Clercq E; Balzarini J
Biochem Pharmacol; 1999 Jul; 58(2):311-23. PubMed ID: 10423173
[TBL] [Abstract][Full Text] [Related]
23. Drug delivery systems: water soluble taxol 2'-poly(ethylene glycol) ester prodrugs-design and in vivo effectiveness.
Greenwald RB; Gilbert CW; Pendri A; Conover CD; Xia J; Martinez A
J Med Chem; 1996 Jan; 39(2):424-31. PubMed ID: 8558510
[TBL] [Abstract][Full Text] [Related]
24. A novel 2'-(N-methylpyridinium acetate) prodrug of paclitaxel induces superior antitumor responses in preclinical cancer models.
Wrasidlo W; Gaedicke G; Guy RK; Renaud J; Pitsinos E; Nicolaou KC; Reisfeld RA; Lode HN
Bioconjug Chem; 2002; 13(5):1093-9. PubMed ID: 12236791
[TBL] [Abstract][Full Text] [Related]
25. Design, synthesis and anticancer activity of fluorocyclopentenyl-purines and - pyrimidines.
Yoon JS; Jarhad DB; Kim G; Nayak A; Zhao LX; Yu J; Kim HR; Lee JY; Mulamoottil VA; Chandra G; Byun WS; Lee SK; Kim YC; Jeong LS
Eur J Med Chem; 2018 Jul; 155():406-417. PubMed ID: 29906687
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and antitumor activity of peptide-paclitaxel conjugates.
Papas S; Akoumianaki T; Kalogiros C; Hadjiarapoglou L; Theodoropoulos PA; Tsikaris V
J Pept Sci; 2007 Oct; 13(10):662-71. PubMed ID: 17787026
[TBL] [Abstract][Full Text] [Related]
27. [Design, synthesis and anti-hBV evaluation of adefovir mono-L-amino acid ester, mono non-steroidal anti-inflammatory drugs carboxylic ester prodrugs].
Fu XZ; Wang YL; Lan YY; Wang AM; Ou Y; Luo C; Li Y
Yao Xue Xue Bao; 2010 Aug; 45(8):1017-24. PubMed ID: 21351588
[TBL] [Abstract][Full Text] [Related]
28. Novel pyrimidine and purine derivatives of L-ascorbic acid: synthesis and biological evaluation.
Raić-Malić S; Hergold-Brundić A; Nagl A; Grdisa M; Pavelić K; De Clercq E; Mintas M
J Med Chem; 1999 Jul; 42(14):2673-8. PubMed ID: 10411487
[TBL] [Abstract][Full Text] [Related]
29. A novel approach of water-soluble paclitaxel prodrug with no auxiliary and no byproduct: design and synthesis of isotaxel.
Hayashi Y; Skwarczynski M; Hamada Y; Sohma Y; Kimura T; Kiso Y
J Med Chem; 2003 Aug; 46(18):3782-4. PubMed ID: 12930140
[TBL] [Abstract][Full Text] [Related]
30. Elongated multiple electronic cascade and cyclization spacer systems in activatible anticancer prodrugs for enhanced drug release.
de Groot FM; Loos WJ; Koekkoek R; van Berkom LW; Busscher GF; Seelen AE; Albrecht C; de Bruijn P; Scheeren HW
J Org Chem; 2001 Dec; 66(26):8815-30. PubMed ID: 11749612
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and biological activity of prodrug inhibitors of the thioredoxin-thioredoxin reductase system.
Wipf P; Lynch SM; Powis G; Birmingham A; Englund EE
Org Biomol Chem; 2005 Nov; 3(21):3880-2. PubMed ID: 16240002
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis and evaluation of novel oxazaphosphorine prodrugs of 9-(2-phosphonomethoxyethyl)adenine (PMEA, adefovir) as potent HBV inhibitors.
Lu P; Liu J; Wang Y; Chen X; Yang Y; Ji R
Bioorg Med Chem Lett; 2009 Dec; 19(24):6918-21. PubMed ID: 19889538
[TBL] [Abstract][Full Text] [Related]
33. Prodrug Strategies for Paclitaxel.
Meng Z; Lv Q; Lu J; Yao H; Lv X; Jiang F; Lu A; Zhang G
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27223283
[TBL] [Abstract][Full Text] [Related]
34. Design and synthesis of a water-soluble taxol analogue: taxol-sialyl conjugate.
Takahashi T; Tsukamoto H; Yamada H
Bioorg Med Chem Lett; 1998 Jan; 8(1):113-6. PubMed ID: 9925441
[TBL] [Abstract][Full Text] [Related]
35. Water-soluble prodrugs of paclitaxel containing self-immolative disulfide linkers.
Gund M; Khanna A; Dubash N; Damre A; Singh KS; Satyam A
Bioorg Med Chem Lett; 2015 Jan; 25(1):122-7. PubMed ID: 25466201
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and in vitro antitumor activity of new butenolide-containing dithiocarbamates.
Wang XJ; Xu HW; Guo LL; Zheng JX; Xu B; Guo X; Zheng CX; Liu HM
Bioorg Med Chem Lett; 2011 May; 21(10):3074-7. PubMed ID: 21486694
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and structure-activity relationships of new antitumor taxoids. Effects of cyclohexyl substitution at the C-3' and/or C-2 of taxotere (docetaxel).
Ojima I; Duclos O; Zucco M; Bissery MC; Combeau C; Vrignaud P; Riou JF; Lavelle F
J Med Chem; 1994 Aug; 37(16):2602-8. PubMed ID: 7914541
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis, and biological evaluation of novel combretastatin A-4 thio derivatives as microtubule targeting agents.
Stefański T; Mikstacka R; Kurczab R; Dutkiewicz Z; Kucińska M; Murias M; Zielińska-Przyjemska M; Cichocki M; Teubert A; Kaczmarek M; Hogendorf A; Sobiak S
Eur J Med Chem; 2018 Jan; 144():797-816. PubMed ID: 29291446
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and evaluation of water-soluble etoposide esters of malic acid as prodrugs.
Chen J; Du W
Med Chem; 2013 Aug; 9(5):740-7. PubMed ID: 23061567
[TBL] [Abstract][Full Text] [Related]
40. Novel prodrugs of tegafur that display improved anticancer activity and antiangiogenic properties.
Engel D; Nudelman A; Tarasenko N; Levovich I; Makarovsky I; Sochotnikov S; Tarasenko I; Rephaeli A
J Med Chem; 2008 Jan; 51(2):314-23. PubMed ID: 18163551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]